Future Intelligent Raises Tens of Millions of RMB in Pre-A+ Round, Co-Led by Qiming Venture Partners
Future Intelligent focuses on R&D and scenario innovation for AI-powered office hardware.
@author-1788515151757110
Future Intelligent focuses on R&D and scenario innovation for AI-powered office hardware.
The ranking aims to offer an objective lens for understanding application trends in China's generative AI space, spotlighting early adopters and benchmark cases that dare to experiment and innovate.
Following Qiming Venture Partners' portfolio companies' milestone moments with you
As China's first independently developed gene therapy for hemophilia B, Xinjiuning® will offer patients a completely new treatment option, with the potential to free them from a lifetime of frequent intravenous injections and help them return to a life without constraints.
The ranking reflects the influence of China's private equity market in the global investment industry.
Beyond its homegrown efficiency advantages, China's biotech sector must also seize the opportunities presented by global collaborative clinical development in the years ahead — leveraging strengths across different regions worldwide to maximize biotech value creation.
Staying with you through the milestone moments of Qiming Venture Partners' portfolio companies
The list aims to identify outstanding companies in China's tech sector that have captured capital market attention while earning recognition from customers and the market — high-tech, high-growth ventures with strong teams, solid reputations, and cross-cycle resilience. It also seeks to honor the best CEOs and best young CEOs who possess international vision, industry insight, and leadership capabilities to steer their enterprises into a new era.
Leveraging WeRide's advanced autonomous driving technology and extensive operational experience, combined with Uber's powerful global mobility platform, the two companies will have the capability and potential to deliver quality services to millions of users worldwide.